XML 58 R42.htm IDEA: XBRL DOCUMENT
v3.21.2

Stockholders’ Equity (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2021
Stockholders’ Equity (Tables) [Line Items] |
Schedule of option grants made to employees |
|  | Year Ended March 31, |
|  | 2021 |  |  | 2020 |
Number of options granted |  |  | 350,000 |  |  |  | 195,000 |
Weighted-average exercise price per share |  | $ | 4.11 |  |  | $ | 2.39 |
Weighted-average grant date fair value per share |  | $ | 1.85 |  |  | $ | 1.14 |
|  | Year Ended March 31, |
|  | 2021 |  |  | 2020 |
Number of units granted |  |  | 1,914,136 |  |  |  | 4,048,306 |
Weighted-average grant date fair value per share |  | $ | 3.15 |  |  | $ | 2.12 |
Schedule of grant date fair value of each of these option grants |
|  | Year Ended March 31, |
|  | 2021 |  |  | 2020 |
Expected volatility |  |  | 53.97% - 73.61 | % |  |  | 47.79% - 50.62 | %
Dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Risk-free rate |  |  | 0.22% - 0.46 | % |  |  | 0.37% - 1.88 | %
Expected term (in years) |  |  | 5.25 - 7.00 |  |  |  | 5.50 - 7.00 |
Schedule of activity of our restricted stock units issued |
|  | Number of Shares |
Outstanding as of April 1, 2019 |  |  | 1,337,391 |
Granted |  |  | 4,048,306 |
Vested |  |  | (761,583 | )
Cancelled |  |  | (93,409 | )
Outstanding as of March 31, 2020 |  |  | 4,530,705 |
Granted |  |  | 1,914,136 |
Vested |  |  | (1,641,082 | )
Cancelled |  |  | (290,843 | )
Outstanding as of March 31, 2021 |  |  | 4,512,916 |
|  | Number of Shares |
Outstanding as of April 1, 2019 |  |  | - |
Granted |  |  | 24,675 |
Outstanding as of March 31, 2020 |  |  | 24,675 |
Granted |  |  | - |
Vested |  |  | - |
Cancelled |  |  | (24,675 | )
Outstanding as of March 31, 2021 |  |  | - |
Schedule of issuances of its restricted common stock to employees |
|  | Number of Shares |  |  | Weighted- Average Grant Date Fair Value per Share |
Unvested as of April 1, 2019 |  |  | 15,278 |  |  | $ | 5.01 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (15,278 | ) |  |  | 5.01 |
Forfeited or expired |  |  | - |  |  |  | - |
Unvested as of March 31, 2020 |  |  | - |  |  |  | - |
Granted |  |  | - |  |  |  | - |
Vested |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |
Unvested as of March 31, 2021 |  |  | - |  |  |  | - |
Schedule of warrant activities |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term (in years) |
Balance outstanding, April 1, 2019 |  |  | 167,363 |  |  | $ | 4.01 |  |  |  | 1.94 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited/expired |  |  | - |  |  |  | - |  |  |  | - |
Balance outstanding, March 31, 2020 |  |  | 167,363 |  |  |  | 4.01 |  |  |  | 0.94 |
Granted |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |
Forfeited/expired |  |  | (167,363 | ) |  |  | 4.01 |  |  |  | 0.94 |
Balance outstanding, March 31, 2021 |  |  | - |  |  |  | - |  |  |  | - |
Exercisable, March 31, 2021 |  |  | - |  |  |  | - |  |  |  | - |
Options to Employees [Member] |
Stockholders’ Equity (Tables) [Line Items] |
Schedule of option grants made to employees |
|  | Number of Shares |  |  | Weighted- Average Exercise Price per Share |
Outstanding as of April 1, 2019 |  |  | 4,880,001 |  |  | $ | 3.95 |
Granted |  |  | 195,000 |  |  |  | 2.39 |
Exercised |  |  | - |  |  |  | - |
Forfeited or expired |  |  | (671,667 | ) |  |  | 4.87 |
Outstanding as of March 31, 2020 |  |  | 4,403,334 |  |  |  | 3.74 |
Granted |  |  | 350,000 |  |  |  | 4.11 |
Exercised |  |  | (654,250 | ) |  |  | 3.90 |
Forfeited or expired |  |  | (177,500 | ) |  |  | 4.00 |
Outstanding as of March 31, 2021 |  |  | 3,921,584 |  |  |  | 3.74 |
Exercisable as of March 31, 2021 |  |  | 3,454,170 |  |  |  | 3.75 |
|  | Number of Shares |  |  | Weighted- Average Exercise Price per Share |
Outstanding as of April 1, 2019 |  |  | 101,667 |  |  | $ | 4.00 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Forfeited or expired |  |  | (76,667 | ) |  |  | 4.00 |
Outstanding as of March 31, 2020 |  |  | 25,000 |  |  |  | 4.00 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Forfeited or expired |  |  | - |  |  |  | - |
Outstanding as of March 31, 2021 |  |  | 25,000 |  |  |  | 4.00 |
Exercisable as of March 31, 2021 |  |  | 25,000 |  |  |  | 4.00 |

X
- References No definition available. + Details
Name: | livx_StockholdersEquityTablesLineItems
Namespace Prefix: | livx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OptionIndexedToIssuersEquityTypeAxis=livx_OptionsToEmployeeOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |